https://doi.org/10.4081/aiua.2022.2.150
The effect of retroperitonealization of ureteroileal anastomosis on perioperative complications of radical cystectomy with ileal conduit urinary diversion
Submitted: May 6, 2022
Accepted: May 19, 2022
Published: June 29, 2022
Accepted: May 19, 2022
Abstract Views: 937
pdf: 445
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Authors
Background: Radical cystectomy (RC) has been considered the standard management of muscle-invasive bladder cancer. Despite the improvements in surgical techniques and perioperative care, RC is still associated with high perioperative morbidity and mortality. Objective: This study aims to evaluate the effect of retroperitonealization of ureteroileal anastomosis on perioperative complications of RC with ileal conduit urinary diversion. Patients and methods: This is a retrospective cohort study. We reviewed medical charts of 876 patients who underwent RC between 2016 and 2021. Based on the inclusion and exclusion criteria, 748 patients entered the study. According to retroperitonealization of the ureteroileal anastomosis, patients were categorized into two groups (group I without retroperitonealization of the ureteroileal anastomosis and group II with retroperitonealization of the ureteroileal anastomosis). Patients’ characteristics and occurrences of any complications and high-grade complications were compared between these groups. Results: In comparing the complication categories between the two groups, fewer patients in group II suffered from gastrointestinal, urinary, and cardiac events (p values were 0.018, 0.021, and 0.013, respectively). Moreover, fewer patients in group II experienced any complications and high-grade complications (p values were < 0.001 and < 0.001, respectively). The length of hospital stay was also significantly shorter in group II (p < 0.001). Conclusions: RC is associated with comparatively high perioperative morbidity and mortality. In the present study, 61% of the patients experienced at least one complication postoperatively. Retroperitonealization of the ureterointestinal anastomosis may decrease perioperative adverse events of RC with ileal conduit urinary diversion.
Sung H, Ferlay J, Siegel RL, et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of incidence and mortality worldwide for 36 Cancers in 185 countries. CA Cancer J Clin. 2021; 71:209-249.
DOI: https://doi.org/10.3322/caac.21660
Kamoun A, de Reyniès A, Allory Y, et al. A consensus molecular classification of muscle-invasive bladder cancer. Eur Urol. 2020; 77:420-33.
DOI: https://doi.org/10.1016/j.eururo.2019.11.011
van Rhijn BW, Burger M, Lotan Y, et al. Recurrence and progression of disease in non-muscle-invasive bladder cancer: from epidemiology to treatment strategy. Eur Urol. 2009; 56:430-42.
DOI: https://doi.org/10.1016/j.eururo.2009.06.028
Witjes JA, Compérat E, Cowan NC, et al. EAU guidelines on muscle-invasive and metastatic bladder cancer: summary of the 2013 guidelines. Eur Urol. 2014; 65:778-92.
DOI: https://doi.org/10.1016/j.eururo.2013.11.046
Neoadjuvant chemotherapy in invasive bladder cancer: update of a systematic review and meta-analysis of individual patient data advanced bladder cancer (ABC) meta-analysis collaboration. Eur Urol. 2005; 48:202-5.
DOI: https://doi.org/10.1016/j.eururo.2005.04.006
Meyer JP, Blick C, Arumainayagam N, et al. A three-centre experience of orthotopic neobladder reconstruction after radical cystectomy: revisiting the initial experience, and results in 104 patients. BJU Int. 2009; 103:680-3.
DOI: https://doi.org/10.1111/j.1464-410X.2008.08204.x
Novotny V, Hakenberg OW, Wiessner D, et al. Perioperative complications of radical cystectomy in a contemporary series. Eur Urol. 2007; 51:397-401.
DOI: https://doi.org/10.1016/j.eururo.2006.06.014
Anderson CB, McKiernan JM. Surgical Complications of Urinary Diversion. Urol Clin North Am. 2018; 45:79-90.
DOI: https://doi.org/10.1016/j.ucl.2017.09.008
Dindo D, Demartines N, Clavien PA. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg. 2004; 240:205-13.
DOI: https://doi.org/10.1097/01.sla.0000133083.54934.ae
Gakis G, Efstathiou J, Lerner SP, et al. ICUD-EAU International Consultation on Bladder Cancer 2012: Radical cystectomy and bladder preservation for muscle-invasive urothelial carcinoma of the bladder. Eur Urol. 2013; 63:45-57.
DOI: https://doi.org/10.1016/j.eururo.2012.08.009
Wallace DM. Ureteric diversion using a conduit: a simplified technique. Br J Urol. 1966; 38:522-7.
DOI: https://doi.org/10.1111/j.1464-410X.1966.tb09747.x
Shabsigh A, Korets R, Vora KC, et al. Defining early morbidity of radical cystectomy for patients with bladder cancer using a standardized reporting methodology. Eur Urol. 2009; 55:164-74.
DOI: https://doi.org/10.1016/j.eururo.2008.07.031
Chang SS, Cookson MS, Baumgartner RG, et al. Analysis of early complications after radical cystectomy: results of a collaborative care pathway. J Urol. 2002; 167:2012-6.
DOI: https://doi.org/10.1016/S0022-5347(05)65074-4
Donat SM, Shabsigh A, Savage C, et al. Potential impact of postoperative early complications on the timing of adjuvant chemotherapy in patients undergoing radical cystectomy: a high-volume tertiary cancer center experience. Eur Urol. 2009; 55:177-85.
DOI: https://doi.org/10.1016/j.eururo.2008.07.018
Hirasawa Y, Nakashima J, Yunaiyama D, et al. Sarcopenia as a novel preoperative prognostic predictor for survival in patients with bladder cancer undergoing radical cystectomy. Ann Surg Oncol. 2016; 23(Suppl 5):1048-54.
DOI: https://doi.org/10.1245/s10434-016-5606-4
Nagele U, Anastasiadis AG, Merseburger AS, et al. The rationale for radical cystectomy as primary therapy for T4 bladder cancer. World J Urol. 2007; 25:401-5.
DOI: https://doi.org/10.1007/s00345-007-0172-9
Takada N, Abe T, Shinohara N, et al. Peri-operative morbidity and mortality related to radical cystectomy: a multi-institutional retrospective study in Japan. BJU Int. 2012; 110:E756-64.
DOI: https://doi.org/10.1111/j.1464-410X.2012.11609.x
Maffezzini M, Fontana V, Pacchetti A, et al. Age above 70 years and Charlson Comorbidity Index higher than 3 are associated with reduced survival probabilities after radical cystectomy for bladder cancer. Data from a contemporary series of 334 consecutive patients. Arch Ital Urol Androl. 2021; 93:15-20.
DOI: https://doi.org/10.4081/aiua.2021.1.15
Kavukoglu Ö, Coskun A, Sabuncu K, et al. Is it possible to reduce the complications and mortality of patients undergoing radical cystectomy? Effectiveness of pre-operative parameters. A prospective study. Arch Ital Urol Androl. 2021; 93:379-84.
DOI: https://doi.org/10.4081/aiua.2021.4.379
Donahue TF, Bochner BH, Sfakianos JP, et al. Risk factors for the development of parastomal hernia after radical cystectomy. J Urol. 2014; 191:1708-13.
DOI: https://doi.org/10.1016/j.juro.2013.12.041
Lawrentschuk N, Colombo R, Hakenberg OW, et al. Prevention and management of complications following radical cystectomy for bladder cancer. Eur Urol. 2010; 57:983-1001.
DOI: https://doi.org/10.1016/j.eururo.2010.02.024
Mayr R, Gierth M, Zeman F, et al. Sarcopenia as a comorbidityindependent predictor of survival following radical cystectomy for bladder cancer. J Cachexia Sarcopenia Muscle. 2018; 9:505-13.
DOI: https://doi.org/10.1002/jcsm.12279
Anaissie J, Dursun F, Wallis CJD, et al. Dissecting the role of radical cystectomy and urinary diversion in post-operative complications: an analysis using the American College of Surgeons national surgical quality improvement program database. Int Braz J Urol. 2021; 47:1006-19.
DOI: https://doi.org/10.1590/s1677-5538.ibju.2020.1098
Madersbacher S, Schmidt J, Eberle JM, et al. Long-term outcome of ileal conduit diversion. J Urol. 2003; 169:985-90.
DOI: https://doi.org/10.1097/01.ju.0000051462.45388.14
Hautmann RE, de Petriconi RC, Volkmer BG. Lessons learned from 1,000 neobladders: the 90-day complication rate. J Urol. 2010; 184:990-4.
DOI: https://doi.org/10.1016/j.juro.2010.05.037
Soleimani M, Moradkhani E, Masoumi N, Gholivandan J. Extraperitoneal versus trans-peritoneal open radical cystectomy - comparison of two techniques in early post-operative complications. Urol J. 2020; 18:519-24.
Kulkarni JN, Agarwal H. Transperitoneal vs. extraperitoneal radical cystectomy for bladder cancer: A retrospective study. Int Braz J Urol. 2018; 44:296-303.
DOI: https://doi.org/10.1590/s1677-5538.ibju.2017.0441
Regan JB, Barrett DM. Stented versus nonstented ureteroileal anastomoses: is there a difference with regard to leak and stricture? J Urol. 1985; 134:1101-3.
DOI: https://doi.org/10.1016/S0022-5347(17)47644-0
Hensle TW, Bredin HC, Dretler SP. Diagnosis and treatment of a urinary leak after ureteroileal conduit for diversion. J Urol. 1976; 116:29-31.
DOI: https://doi.org/10.1016/S0022-5347(17)58660-7
Kavaric P, Eldin S, Nenad R, et al. Modified Wallace anastomotic technique reduces ureteroenteric stricture rates after ileal conduit urinary diversion. Int Braz J Urol. 2020; 46:446-55.
DOI: https://doi.org/10.1590/s1677-5538.ibju.2019.0417
How to Cite
Ariafar, A., Salehipour, M., Zeyghami, S., & Rezaei, M. (2022). The effect of retroperitonealization of ureteroileal anastomosis on perioperative complications of radical cystectomy with ileal conduit urinary diversion. Archivio Italiano Di Urologia E Andrologia, 94(2), 150–154. https://doi.org/10.4081/aiua.2022.2.150
PAGEPress has chosen to apply the Creative Commons Attribution NonCommercial 4.0 International License (CC BY-NC 4.0) to all manuscripts to be published.